A family-owned Iowa seed company has sued Bayer, claiming the Germany-based agribusiness used illegal and anti-competitive practices to secure dominance over the U.S. market for genetically engineered corn seeds. The civil complaint, filed last month and made public on Tuesday, names Bayer as having the power to set prices and exclude rivals, and alleges the company profited by "hundreds of millions, if not billions, of ill-gotten dollars."
The lawsuit was lodged in the U.S. District Court for the Eastern District of Missouri by Latham Quality, which says the concentrated structure of the U.S. seed industry enabled Bayer to impose tactics that raised costs for both farmers and independent seed companies. The filing proposes a class action and asks the court to award treble damages to Latham and other similarly situated firms, according to court documents.
At the center of the complaint is Bayers control of a genetic trait known as NK603, which renders corn tolerant to Bayers widely used herbicide Roundup. Lathams lawsuit says nearly all genetically engineered hybrid corn seed sold in the United States contain the NK603 trait. The complaint also cites a U.S. government estimate that roughly 92% of corn acres are planted with herbicide-tolerant seeds.
Latham contends that demand for NK603 remained strong even after Bayers last patent on the trait expired in 2022, yet no effective competitors emerged. The complaint attributes the absence of generics to Bayers alleged anti-competitive conduct, including restrictions on the use of Bayers genetic material by independent seed companies after patent expiration, continued collection of royalties, and increases in licensing fees.
According to the complaint, Latham held a license from Bayer or Monsanto to include NK603 in corn seeds it produced and sold. Latham says it later began developing its own corn seed product that would have competed with Bayers offering. That effort, the lawsuit alleges, was met with pressure from a Bayer representative who told Latham to "stay 100% loyal to Bayer." When Latham continued its development, the complaint says Bayer-aligned sales representatives retaliated by using non-public information to divert business, leaving Latham near bankruptcy.
Lathams president, John Latham, has previously expressed concerns about the growing power of multinational seed and fertilizer firms. In testimony before a U.S. Senate Judiciary Committee hearing on competition in the seed and fertilizer sectors in October, he said independent companies were being driven out of business by what he described as predatory behavior.
The civil suit adds to broader legal pressure facing Bayer. The company is defending thousands of other lawsuits claiming its Roundup weedkiller causes cancer. Separately, the U.S. Department of Justice said last week that Bayer removed provisions from a loyalty program that could be viewed as potentially anti-competitive for independent seed companies that license Bayer technology to make seed.
Bayer, which acquired U.S. seed producer Monsanto in 2018, said on Wednesday it believes the allegations lack merit and that it will answer the claims in court. The company stated it competes fairly across its agricultural operations and is in compliance with applicable laws. "The crop input and corn seed markets are competitive, fair and diverse," Bayer added in its response.
For crop producers, the complaint highlights cost pressures that have tightened farm margins. U.S. farmers, the suit notes, have been contending with elevated prices for seeds, fuel and fertilizer, and the sector was facing a fourth consecutive year of margin compression. Lathams complaint frames Bayers conduct as contributing to higher input costs for both growers and independent seed suppliers.
The suit further underscores the role of licensing and royalty arrangements in the seed industry. Latham alleges that Bayer continued to charge royalties on seed grown from Bayers genetic material even after the expiration of patents, and that licensing fees were raised for companies such as Latham. Those claims form part of Lathams argument that Bayer used contractual and commercial mechanisms to limit competition and maintain control over the market for NK603-bearing hybrid corn.
In a financial snapshot included in public filings, Bayer reported that its Crop Science unit, which includes seeds, delivered a 17.9% increase in first-quarter earnings to 3 billion euros, a figure reported alongside the exchange rate of $1 = 0.8601 euros. While the lawsuit seeks financial remedies for independent seed companies and affected farmers, Bayer insists the markets remain competitive.
The complaint joins a broader policy conversation about competition in food supply chains that has gained attention at the federal level. The lawsuits timing also coincides with statements from political leaders that their administrations will scrutinize anti-competitive practices in those sectors. For now, the claims in the Latham suit will proceed through the federal court system, where they will be tested against Bayers denial of wrongdoing.
Summary
Latham Quality, an Iowa family-owned seed producer, filed a federal lawsuit alleging Bayer used illegal tactics to monopolize the U.S. genetically engineered corn seed market. The complaint focuses on Bayers control of the NK603 trait, claims of continued royalties and restrictive licensing after patent expiration in 2022, and alleged retaliation against Latham when it attempted to develop competing seed. Bayer denies the allegations and says it complies with the law.
Key points
- Latham alleges Bayer monopolized the U.S. market for NK603-bearing corn seed and seeks treble damages through a proposed class action.
- The lawsuit asserts Bayer restricted independent seed companies from developing generics after NK603 patents expired in 2022 and continued charging royalties and raising licensing fees.
- Impacted sectors include agriculture and crop inputs, independent seed producers, and farm economics, as higher seed costs are cited amid broader margin pressures for U.S. crop farmers.
Risks and uncertainties
- Legal uncertainty for Bayer and independent seed firms as the court evaluates claims of anti-competitive conduct and potential class certification.
- Potential financial exposure for Bayer if treble damages are awarded, which could affect stakeholders in the agricultural supply chain.
- Market concentration concerns may continue to exert pressure on independent seed companies and on farm input costs, which could influence margins in the farming sector.